Particles for Humanity and Hexagon Nutrition Complete PFH-VAP Manufacturing Transfer

CAMBRIDGE, Mass. and MUMBAI, India, Sept. 23, 2026 /PRNewswire/ -- Particles for Humanity and Hexagon Nutrition Limited today announced the successful completion of commercial-scale process validation for PFH-VAP, to be sold commercially as VIT A+, a stable formulation of vitamin A palmitate developed for large-scale food fortification. The validation campaign was conducted by Hexagon Nutrition in India, and completed the transfer of manufacturing from LIS by Lesaffre's site in France.

VIT A+ was designed to improve the stability of vitamin A during storage and cooking under conditions commonly encountered in low- and middle-income countries. Successful process validation demonstrates that it can be produced consistently at commercial scale while maintaining the key product attributes established during development. Each commercial-scale batch produces enough VIT A+ to fortify 600 million servings of food. The transfer is expected to enable more cost-effective production, helping expand access in regions where vitamin A deficiency remains high.

"Completing this manufacturing transfer is a major milestone in the development of PFH-VAP and brings us one step closer to making this technology broadly available through food fortification programs," said Sherri C. Oberg, Chief Executive Officer and Co-founder of Particles for Humanity. "This achievement reflects years of collaboration among scientists, engineers, and manufacturing partners committed to reducing the burden of vitamin A deficiency. We are excited to see PFH-VAP positioned for the next phase of commercialization."

Following the 2025 announcement of their partnership, Particles for Humanity and Hexagon Nutrition worked together to transfer manufacturing knowledge and prepare VIT A+ for commercial supply.

"At Hexagon Nutrition, improving nutrition through innovation is central to our mission," said Vikram Kelkar, Managing Director of Hexagon Nutrition Limited. "The completion of process validation demonstrates that VIT A+ can be manufactured reliably at commercial scale and reflects the strong collaboration between our organizations. We look forward to working with partners across the food fortification ecosystem to expand access to stable vitamin A."

With manufacturing transfer and validation complete, Particles for Humanity and Hexagon Nutrition will focus on advancing adoption of VIT A+ and supporting its use in fortification programs designed to improve nutrition outcomes for vulnerable populations, including in foods like bouillon, flour, and sugar.

Particles for Humanity transforms early-stage medical technology into products for people living in low and lower-middle income countries. Its rigorous product development process is based on end-user input. Particles for Humanity is funded solely with philanthropy and is focused on financially sustainable product opportunities. Visit www.particlesfh.com or contact [email protected]

Hexagon Nutrition is a differentiated and research-oriented pure-play nutrition company offering clinical nutrition solutions products, micronutrient premixes, and therapeutic products. Hexagon Nutrition has presence across retail pharmacies, hospitals, and prominent e-commerce players. Hexagon markets products across India and exports to more than 70 countries.

CONTACT: [email protected]

SOURCE Particles for Humanity